Although these findings raise the question of whether TREM2 agonism or antagonism may be more beneficial in the context of AD, they also highlight the need for basic studies that interrogate the ligand-specific activation of TREM2-mediated signaling. Here, TREM2 is linked to Alzheimer disease.